These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 32513782)
21. LncRNA-TCONS_00034812 in cell proliferation and apoptosis of pulmonary artery smooth muscle cells and its mechanism. Liu Y; Sun Z; Zhu J; Xiao B; Dong J; Li X J Cell Physiol; 2018 Jun; 233(6):4801-4814. PubMed ID: 29150946 [TBL] [Abstract][Full Text] [Related]
22. Osthole alleviates pulmonary vascular remodeling by modulating microRNA-22-3p mediated lipid metabolic reprogramming. Niu Z; Fu M; Li Y; Ren H; Zhang X; Yao L Phytomedicine; 2022 Feb; 96():153840. PubMed ID: 34836745 [TBL] [Abstract][Full Text] [Related]
23. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target. Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats. Cheng Y; Yu M; Xu J; He M; Wang H; Kong H; Xie W BMC Pulm Med; 2018 Aug; 18(1):130. PubMed ID: 30086741 [TBL] [Abstract][Full Text] [Related]
25. Secretory clusterin is upregulated in rats with pulmonary arterial hypertension induced by systemic-to-pulmonary shunts and exerts important roles in pulmonary artery smooth muscle cells. Liu X; Meng L; Li J; Meng J; Teng X; Gu H; Hu S; Wei Y Acta Physiol (Oxf); 2015 Feb; 213(2):505-18. PubMed ID: 25069740 [TBL] [Abstract][Full Text] [Related]
28. Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension. Nakamura K; Sakaguchi M; Matsubara H; Akagi S; Sarashina T; Ejiri K; Akazawa K; Kondo M; Nakagawa K; Yoshida M; Miyoshi T; Ogo T; Oto T; Toyooka S; Higashimoto Y; Fukami K; Ito H PLoS One; 2018; 13(9):e0203046. PubMed ID: 30180189 [TBL] [Abstract][Full Text] [Related]
29. MiR-18a-5p contributes to enhanced proliferation and migration of PASMCs via targeting Notch2 in pulmonary arterial hypertension. Miao R; Liu W; Qi C; Song Y; Zhang Y; Fu Y; Liu W; Lang Y; Zhang Y; Zhang Z Life Sci; 2020 Sep; 257():117919. PubMed ID: 32585247 [TBL] [Abstract][Full Text] [Related]
30. Dysregulation of miR-135a-5p promotes the development of rat pulmonary arterial hypertension in vivo and in vitro. Liu HM; Jia Y; Zhang YX; Yan J; Liao N; Li XH; Tang Y Acta Pharmacol Sin; 2019 Apr; 40(4):477-485. PubMed ID: 30038339 [TBL] [Abstract][Full Text] [Related]
31. Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension. Van der Feen DE; Kurakula K; Tremblay E; Boucherat O; Bossers GPL; Szulcek R; Bourgeois A; Lampron MC; Habbout K; Martineau S; Paulin R; Kulikowski E; Jahagirdar R; Schalij I; Bogaard HJ; Bartelds B; Provencher S; Berger RMF; Bonnet S; Goumans MJ Am J Respir Crit Care Med; 2019 Oct; 200(7):910-920. PubMed ID: 31042405 [No Abstract] [Full Text] [Related]
32. MMP-10 from M1 macrophages promotes pulmonary vascular remodeling and pulmonary arterial hypertension. Chi PL; Cheng CC; Hung CC; Wang MT; Liu HY; Ke MW; Shen MC; Lin KC; Kuo SH; Hsieh PP; Wann SR; Huang WC Int J Biol Sci; 2022; 18(1):331-348. PubMed ID: 34975336 [TBL] [Abstract][Full Text] [Related]
33. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation. Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454 [TBL] [Abstract][Full Text] [Related]
34. Targeting TMEM16A to reverse vasoconstriction and remodelling in idiopathic pulmonary arterial hypertension. Papp R; Nagaraj C; Zabini D; Nagy BM; Lengyel M; Skofic Maurer D; Sharma N; Egemnazarov B; Kovacs G; Kwapiszewska G; Marsh LM; Hrzenjak A; Höfler G; Didiasova M; Wygrecka M; Sievers LK; Szucs P; Enyedi P; Ghanim B; Klepetko W; Olschewski H; Olschewski A Eur Respir J; 2019 Jun; 53(6):. PubMed ID: 31023847 [TBL] [Abstract][Full Text] [Related]
37. Implication of EZH2 in the Pro-Proliferative and Apoptosis-Resistant Phenotype of Pulmonary Artery Smooth Muscle Cells in PAH: A Transcriptomic and Proteomic Approach. Habbout K; Omura J; Awada C; Bourgeois A; Grobs Y; Krishna V; Breuils-Bonnet S; Tremblay E; Mkannez G; Martineau S; Nadeau V; Roux-Dalvai F; Orcholski M; Jeyaseelan J; Gutstein D; Potus F; Provencher S; Bonnet S; Paulin R; Boucherat O Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803922 [TBL] [Abstract][Full Text] [Related]
38. Isorhynchophylline protects against pulmonary arterial hypertension and suppresses PASMCs proliferation. Guo H; Zhang X; Cui Y; Deng W; Xu D; Han H; Wang H; Chen Y; Li Y; Wu D Biochem Biophys Res Commun; 2014 Jul; 450(1):729-34. PubMed ID: 24950404 [TBL] [Abstract][Full Text] [Related]